McKesson Corporation (MCK) - Net Assets
Based on the latest financial reports, McKesson Corporation (MCK) has net assets worth $-834.00 Million USD as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($82.32 Billion) and total liabilities ($83.16 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check MCK tangible net assets ratio to evaluate the tangible quality of the company's equity base.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $-834.00 Million |
| % of Total Assets | -1.01% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | -106.62% |
| Growth Volatility | 51.38 |
McKesson Corporation - Net Assets Trend (1995–2026)
This chart illustrates how McKesson Corporation's net assets have evolved over time, based on quarterly financial data. See McKesson Corporation defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Annual Net Assets for McKesson Corporation (1995–2026)
The table below shows the annual net assets of McKesson Corporation from 1995 to 2026. For live valuation and market cap data, see MCK stock market capitalisation.
| Year | Net Assets | Change |
|---|---|---|
| 2026-03-31 | $-834.00 Million | +50.77% |
| 2025-03-31 | $-1.69 Billion | -5.94% |
| 2024-03-31 | $-1.60 Billion | -7.32% |
| 2023-03-31 | $-1.49 Billion | +16.85% |
| 2022-03-31 | $-1.79 Billion | -223.93% |
| 2021-03-31 | $1.45 Billion | -78.45% |
| 2020-03-31 | $6.71 Billion | -30.67% |
| 2019-03-31 | $9.68 Billion | -15.94% |
| 2018-03-31 | $11.52 Billion | -8.60% |
| 2017-03-31 | $12.60 Billion | +20.99% |
| 2016-03-31 | $10.41 Billion | +9.96% |
| 2015-03-31 | $9.47 Billion | -8.21% |
| 2014-03-31 | $10.32 Billion | +45.94% |
| 2013-03-31 | $7.07 Billion | +3.50% |
| 2012-03-31 | $6.83 Billion | -5.39% |
| 2011-03-31 | $7.22 Billion | -4.14% |
| 2010-03-31 | $7.53 Billion | +21.62% |
| 2009-03-31 | $6.19 Billion | +1.18% |
| 2008-03-31 | $6.12 Billion | -2.42% |
| 2007-03-31 | $6.27 Billion | +6.20% |
| 2006-03-31 | $5.91 Billion | +11.98% |
| 2005-03-31 | $5.28 Billion | +2.13% |
| 2004-03-31 | $5.17 Billion | +9.32% |
| 2003-03-31 | $4.72 Billion | +14.23% |
| 2002-03-31 | $4.14 Billion | +12.13% |
| 2001-03-31 | $3.69 Billion | -1.94% |
| 2000-03-31 | $3.76 Billion | +22.23% |
| 1999-03-31 | $3.08 Billion | +92.07% |
| 1998-03-31 | $1.60 Billion | +10.07% |
| 1997-03-31 | $1.46 Billion | +29.76% |
| 1996-03-31 | $1.12 Billion | +4.51% |
| 1995-03-31 | $1.07 Billion | -- |
Equity Component Analysis
This analysis shows how different components contribute to McKesson Corporation's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 2444.9% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (March 2026)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | $22.29 Billion | % |
| Common Stock | $3.00 Million | % |
| Other Comprehensive Income | $-1.45 Billion | % |
| Total Equity | $-2.17 Billion | 100.00% |
McKesson Corporation Competitors by Market Cap
The table below lists competitors of McKesson Corporation ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Compagnie Financière Richemont SA
SW:CFR
|
$90.72 Billion |
|
CHRISTIAN DIOR ADR1/4/EO2
F:DIO0
|
$91.96 Billion |
|
Blackstone Group Inc
NYSE:BX
|
$91.96 Billion |
|
Glencore plc
MX:GLENN
|
$92.20 Billion |
|
Barclays PLC
MX:BCSN
|
$89.91 Billion |
|
Vertiv Holdings Co
NYSE:VRT
|
$89.72 Billion |
|
SK Square Co Ltd
KO:402340
|
$89.70 Billion |
|
The Bank of New York Mellon Corporation
NYSE:BK
|
$89.57 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in McKesson Corporation's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2025 to 2026, total equity changed from -1,694,000,000 to -2,172,000,000, a change of -478,000,000.
- Net income of 4,762,000,000 contributed positively to equity growth.
- Dividend payments of 381,000,000 reduced retained earnings.
- Share repurchases of 4,750,000,000 reduced equity.
- New share issuances of 89,000,000 increased equity.
- Other comprehensive income decreased equity by 521,000,000.
- Other factors increased equity by 323,000,000.
Equity Change Factors (2025 to 2026)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $4.76 Billion | +219.24% |
| Dividends Paid | $381.00 Million | -17.54% |
| Share Repurchases | $4.75 Billion | -218.69% |
| Share Issuances | $89.00 Million | +4.1% |
| Other Comprehensive Income | $-521.00 Million | -23.99% |
| Other Changes | $323.00 Million | +14.87% |
| Total Change | $- | % |
Book Value vs Market Value Analysis
This analysis compares McKesson Corporation's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 1995-03-31 | $11.76 | $750.63 | x |
| 1996-03-31 | $12.01 | $750.63 | x |
| 1997-03-31 | $17.25 | $750.63 | x |
| 1998-03-31 | $16.76 | $750.63 | x |
| 1999-03-31 | $11.18 | $750.63 | x |
| 2000-03-31 | $13.24 | $750.63 | x |
| 2001-03-31 | $13.03 | $750.63 | x |
| 2002-03-31 | $13.88 | $750.63 | x |
| 2003-03-31 | $15.81 | $750.63 | x |
| 2004-03-31 | $17.28 | $750.63 | x |
| 2005-03-31 | $17.94 | $750.63 | x |
| 2006-03-31 | $18.69 | $750.63 | x |
| 2007-03-31 | $20.57 | $750.63 | x |
| 2008-03-31 | $20.54 | $750.63 | x |
| 2009-03-31 | $22.20 | $750.63 | x |
| 2010-03-31 | $27.59 | $750.63 | x |
| 2011-03-31 | $27.45 | $750.63 | x |
| 2012-03-31 | $27.22 | $750.63 | x |
| 2013-03-31 | $29.58 | $750.63 | x |
| 2014-03-31 | $44.28 | $750.63 | x |
| 2015-03-31 | $40.30 | $750.63 | x |
| 2016-03-31 | $44.70 | $750.63 | x |
| 2017-03-31 | $56.50 | $750.63 | x |
| 2018-03-31 | $55.10 | $750.63 | x |
| 2019-03-31 | $49.06 | $750.63 | x |
| 2020-03-31 | $36.87 | $750.63 | x |
| 2021-03-31 | $9.00 | $750.63 | x |
| 2022-03-31 | $-11.63 | $750.63 | x |
| 2023-03-31 | $-10.48 | $750.63 | x |
| 2024-03-31 | $-11.92 | $750.63 | x |
| 2025-03-31 | $-13.22 | $750.63 | x |
| 2026-03-31 | $-17.50 | $750.63 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently McKesson Corporation utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 1.18%
- • Asset Turnover: 4.90x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is below the historical average (1.28%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 1995 | 37.68% | 3.07% | 3.79x | 3.24x | $297.16 Million |
| 1996 | 12.07% | 0.99% | 3.91x | 3.12x | $23.22 Million |
| 1997 | 9.20% | 1.04% | 2.49x | 3.55x | $-11.66 Million |
| 1998 | 9.67% | 0.74% | 3.72x | 3.50x | $-5.32 Million |
| 1999 | 2.76% | 0.28% | 3.35x | 2.95x | $-222.84 Million |
| 2000 | 19.24% | 1.97% | 3.54x | 2.76x | $347.54 Million |
| 2001 | -1.31% | -0.11% | 3.64x | 3.13x | $-417.18 Million |
| 2002 | 10.12% | 0.84% | 3.75x | 3.22x | $4.98 Million |
| 2003 | 11.75% | 0.97% | 3.98x | 3.04x | $82.92 Million |
| 2004 | 12.52% | 0.93% | 4.28x | 3.14x | $129.97 Million |
| 2005 | -2.98% | -0.19% | 4.29x | 3.56x | $-684.51 Million |
| 2006 | 12.49% | 0.84% | 4.20x | 3.55x | $147.30 Million |
| 2007 | 15.35% | 1.04% | 3.88x | 3.82x | $335.70 Million |
| 2008 | 16.17% | 0.97% | 4.13x | 4.02x | $377.90 Million |
| 2009 | 13.29% | 0.77% | 4.22x | 4.08x | $203.70 Million |
| 2010 | 16.77% | 1.16% | 3.86x | 3.74x | $509.80 Million |
| 2011 | 15.65% | 1.01% | 3.63x | 4.28x | $408.00 Million |
| 2012 | 20.54% | 1.14% | 3.71x | 4.84x | $719.90 Million |
| 2013 | 18.93% | 1.09% | 3.52x | 4.92x | $631.00 Million |
| 2014 | 12.24% | 0.92% | 2.66x | 5.02x | $231.20 Million |
| 2015 | 15.58% | 0.82% | 3.32x | 5.69x | $528.90 Million |
| 2016 | 21.68% | 1.18% | 3.37x | 5.43x | $1.22 Billion |
| 2017 | 41.13% | 2.61% | 3.26x | 4.84x | $3.92 Billion |
| 2018 | 0.58% | 0.03% | 3.45x | 5.24x | $-1.08 Billion |
| 2019 | 0.35% | 0.02% | 3.59x | 6.16x | $-934.00 Million |
| 2020 | 13.41% | 0.39% | 3.77x | 9.13x | $228.90 Million |
| 2021 | -313.90% | -1.91% | 3.66x | 44.96x | $-4.68 Billion |
| 2022 | 0.00% | 0.42% | 4.17x | 0.00x | $1.29 Billion |
| 2023 | 0.00% | 1.29% | 4.44x | 0.00x | $3.71 Billion |
| 2024 | 0.00% | 0.97% | 4.58x | 0.00x | $3.16 Billion |
| 2025 | 0.00% | 0.92% | 4.78x | 0.00x | $3.46 Billion |
| 2026 | 0.00% | 1.18% | 4.90x | 0.00x | $4.98 Billion |
Industry Comparison
This section compares McKesson Corporation's net assets metrics with peer companies in the Medical Distribution industry.
Industry Context
- Industry: Medical Distribution
- Average net assets among peers: $609,123,708
- Average return on equity (ROE) among peers: -11.84%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| McKesson Corporation (MCK) | $-834.00 Million | 37.68% | N/A | $90.23 Billion |
| Accendra Health Inc (ACH) | $565.23 Million | -64.17% | 7.24x | $246.89 Million |
| Akso Health Group ADR (AHG) | $12.29 Million | -137.15% | 3.13x | $807.33 Million |
| Cardinal Health Inc (CAH) | $1.33 Billion | 13.59% | 1.33x | $43.01 Billion |
| Cencora Inc. (COR) | $2.46 Billion | 29.27% | 5.29x | $50.53 Billion |
| Cosmos Health Inc. (COSM) | $-6.46 Million | 0.00% | 0.00x | $11.14 Million |
| EDAP TMS SA (EDAP) | $17.36 Million | -6.13% | 0.66x | $154.80 Million |
| Empro Group Inc. Ordinary shares (EMPG) | $1.53 Million | 49.22% | 2.01x | $143.05 Million |
| Henry Schein Inc (HSIC) | $867.97 Million | 13.59% | 0.80x | $7.86 Billion |
| Owens & Minor Inc (OMI) | $235.30 Million | -4.80% | 2.65x | $185.63 Million |
About McKesson Corporation
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: North American Pharmaceutical, Oncology & Multispecialty, Prescription Technology Solutions, and Medical-Surgical Solutions. The company distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products; d… Read more